Late Life Depression study: High-intensity
Official title tDCS for Late-Life Depression
ClinicalTrials.gov ID: NCT07657234
What this study is testing
- What it's testing
- This study is testing whether a gentle electric current helps with late-life depression. It also checks if the treatment is safe and how well people can handle it.
- Who it's for
- You may be able to join if you are 60 or older and have late-life depression.
- What's involved
- You would get a gentle electric current on your head. This happens three times a week for three weeks.
- Time commitment
- The study lasts three weeks with visits three times a week.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 and older
You may be able to join if
- age 60 years or older;
- diagnosis of unipolar major depressive disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)...
- score of 16 or higher on the Quick Inventory of Depressive Symptomology-Clinician Rated (QIDS-C) at screening;
- stable antidepressant regimen for at least four weeks prior to enrollment, if applicable;
- willingness and capacity to provide informed consent;
You likely can't join if
- contraindications to tDCS including metallic cranial implants, skin conditions at electrode sites (eczema, open wounds, burns, lesions), or history...
- contraindications to magnetic resonance imaging (MRI) including pacemaker, cochlear implants, ferromagnetic implants, or claustrophobia;
- depressive disorder due to a medical condition;
- psychotic depression;
- history of seizures or epilepsy;
- bipolar disorder;
See the full eligibility criteria
- age 60 years or older;
- diagnosis of unipolar major depressive disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), confirmed by the Structured Clinical Interview for DSM-5 (SCID-5);
- score of 16 or higher on the Quick Inventory of Depressive Symptomology-Clinician Rated (QIDS-C) at screening;
- stable antidepressant regimen for at least four weeks prior to enrollment, if applicable;
- willingness and capacity to provide informed consent;
- Clinical Dementia Rating scale of 0 or 0.5.
- availability of an informant who has sufficient knowledge of the participant's daily functioning as ascertained by the study team.
- contraindications to tDCS including metallic cranial implants, skin conditions at electrode sites (eczema, open wounds, burns, lesions), or history of adverse reaction to tDCS;
- contraindications to magnetic resonance imaging (MRI) including pacemaker, cochlear implants, ferromagnetic implants, or claustrophobia;
- depressive disorder due to a medical condition;
- psychotic depression;
- history of seizures or epilepsy;
- bipolar disorder;
- psychotic disorders;
- severe personality disorder;
- active substance use disorder within the past six months or history of substance induced mood or psychotic disorder;
- neuromodulation treatment including electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), tDCS, or vagus nerve stimulation (VNS) within the past six months;
- active suicidal ideation with plan or intent requiring a higher level of care;
- concurrent use of medications that substantially lower seizure threshold;
- pregnancy;
- a clinically established diagnosis of dementia as reported in the participant's health record or scoring 1 or above on CDR;
- medically unstable in the clinical opinion of the principal investigators.
The study team makes the final eligibility decision.
Where it is enrolling
- Dallas, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Dallas, Texas, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.